Sponsor Pipeline

AIDS Malignancy Consortium Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
11
Active Trials
6
Recruiting
1
Phase 3
6
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-12 NCT05797662
A Study of Propranolol to Treat Kaposi Sarcoma
Trial sites reduced: 9 -> 6 locations
Active Trials by Phase
Phase 3
1
Phase 2
4
Phase 1/2
1
Phase 1
1
Early Phase 1
1
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05411237 Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma Kaposi Sarcoma Not Yet Recruiting
Phase 2
NCT04305691 Trial of Ixazomib for Kaposi Sarcoma Kaposi Sarcoma Recruiting
NCT07539454 Nirogacestat in Patients With Kaposi Sarcoma AIDS-Related Kaposi Sarcoma Not Yet Recruiting
NCT05797662 A Study of Propranolol to Treat Kaposi Sarcoma Kaposi Sarcoma Not Yet Recruiting
NCT07662928 Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma… Adult Burkitt Lymphoma Not Yet Recruiting
Phase 1/2
NCT02797470 Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma… HIV Infection Active, Not Recruiting
Phase 1
NCT05077527 Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin… AIDS-Related Diffuse Large B-cell Lymphoma Recruiting
Early Phase 1
NCT04139304 A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma Plasmablastic Lymphoma Recruiting
Not specified
NCT04704648 Feasibility Study of Ocular Surface Squamous Neoplasia Surgical Excision in People Living… Ocular Surface Squamous Neoplasia Recruiting
NCT05663502 Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers Anal Carcinoma Recruiting
NCT04949464 Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking… HIV Infection Recruiting
Disease Areas
Get alerts when AIDS Malignancy Consortium's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free